Tscan Therapeutics Inc (TCRX)

10:09 AM

Should you wait for a breakout in TScan Therapeutics Inc.July 2025 Technicals & Safe Entry Trade Reports - newser.com

10:09 AM

01:58 AM

What technical models suggest about TScan Therapeutics Inc.’s comeback - newser.com

01:58 AM

01:06 AM

How TScan Therapeutics Inc. stock reacts to global recession fearsAnalyst Downgrade & Safe Capital Growth Plans - newser.com

01:06 AM

Nov 06, 2025

Trend analysis for TScan Therapeutics Inc. this weekGap Down & Weekly Market Pulse Updates - newser.com

Nov 06, 2025

Nov 06, 2025

FY2025 EPS Forecast for TScan Therapeutics Raised by Analyst - Defense World

Nov 06, 2025

Nov 06, 2025

Applying chart zones and confluence areas to TScan Therapeutics Inc.Weekly Trade Analysis & Low Volatility Stock Recommendations - newser.com

Nov 06, 2025

Nov 06, 2025

Applying sector rotation models to TScan Therapeutics Inc.Weekly Trend Recap & Free Technical Pattern Based Buy Signals - newser.com

Nov 06, 2025

Nov 06, 2025

How TScan Therapeutics Inc. stock reacts to inflationary pressuresJuly 2025 Market Mood & Low Risk Profit Maximizing Plans - fcp.pa.gov.br

Nov 06, 2025

Nov 06, 2025

Reversal indicators forming on TScan Therapeutics Inc. stockJuly 2025 Selloffs & Smart Investment Allocation Insights - newser.com

Nov 06, 2025

Nov 06, 2025

How TScan Therapeutics Inc. stock performs in rate cut cyclesJuly 2025 Fed Impact & Technical Buy Zone Confirmations - newser.com

Nov 06, 2025

Nov 06, 2025

Is TScan Therapeutics Inc. stock attractive for ETFsCPI Data & AI Driven Price Forecasts - fcp.pa.gov.br

Nov 06, 2025

Nov 06, 2025

Using data filters to optimize entry into TScan Therapeutics Inc.2025 Top Decliners & Consistent Return Investment Signals - newser.com

Nov 06, 2025

Nov 06, 2025

Can TScan Therapeutics Inc. stock maintain growth trajectoryPrice Action & Advanced Swing Trade Entry Plans - newser.com

Nov 06, 2025

Nov 06, 2025

Growth Value: Will TScan Therapeutics Inc. stock benefit from green energy trendsEarnings Recap Summary & Detailed Earnings Play Strategies - fcp.pa.gov.br

Nov 06, 2025

Nov 05, 2025

Technical signs of recovery in TScan Therapeutics Inc.GDP Growth & Daily Entry Point Trade Alerts - newser.com

Nov 05, 2025

Nov 05, 2025

Can swing trading help recover from TScan Therapeutics Inc. lossesEarnings Miss & Fast Gain Stock Trading Tips - newser.com

Nov 05, 2025

Nov 05, 2025

Is TScan Therapeutics Inc. stock positioned well for digital economy2025 Top Gainers & Technical Pattern Alert System - newser.com

Nov 05, 2025

Nov 05, 2025

TScan Therapeutics (NASDAQ:TCRX) Price Target Cut to $6.00 by Analysts at Needham & Company LLC - Defense World

Nov 05, 2025

Nov 05, 2025

TScan Therapeutics (TCRX) Projected to Post Earnings on Tuesday - MarketBeat

Nov 05, 2025

Nov 05, 2025

TScan Therapeutics (NASDAQ:TCRX) Price Target Lowered to $6.00 at Needham & Company LLC - MarketBeat

Nov 05, 2025

Nov 05, 2025

The time has not yet come to remove your chips from the table: Tscan Therapeutics Inc (TCRX) - setenews.com

Nov 05, 2025

Nov 05, 2025

TScan Therapeutics to Participate in the Guggenheim 2nd Annual Healthcare Innovation Conference - The Manila Times

Nov 05, 2025

Nov 05, 2025

Barclays Reaffirms Their Buy Rating on TScan Therapeutics (TCRX) - The Globe and Mail

Nov 05, 2025

Nov 05, 2025

Best data tools to analyze TScan Therapeutics Inc. stockWeekly Market Report & Expert Curated Trade Setup Alerts - newser.com

Nov 05, 2025

Nov 05, 2025

How TScan Therapeutics Inc. stock performs in high volatility marketsCPI Data & Accurate Entry and Exit Point Alerts - newser.com

Nov 05, 2025

Nov 04, 2025

TScan Therapeutics Shares Fall After BTIG Research Downgrade - MarketScreener

Nov 04, 2025

Nov 04, 2025

Biotech firm TScan slashes jobs, extends cash runway amid strategic realignment - The Business Journals

Nov 04, 2025

Nov 04, 2025

BTIG downgrades Tscan Therapeutics stock to Neutral on program delays By Investing.com - Investing.com Australia

Nov 04, 2025

Nov 04, 2025

BTIG downgrades Tscan Therapeutics stock to Neutral on program delays - Investing.com India

Nov 04, 2025

Nov 04, 2025

BTIG Research Downgrades TScan Therapeutics to Neutral From Buy - MarketScreener

Nov 04, 2025

Nov 04, 2025

Needham Maintains TScan Therapeutics (TCRX) Buy Recommendation - Nasdaq

Nov 04, 2025

Nov 04, 2025

TScan Therapeutics (TCRX) Analyst Update: Needham Lowers Price T - GuruFocus

Nov 04, 2025

Nov 03, 2025

TScan to focus on heme program, cuts workforce by 30% amid FDA progress - Investing.com Nigeria

Nov 03, 2025

Nov 03, 2025

Is TScan Therapeutics Inc. stock gaining market shareVolume Spike & Growth Oriented Trade Recommendations - fcp.pa.gov.br

Nov 03, 2025

Nov 03, 2025

Tscan Therapeutics stock plunges after pausing solid tumor trial enrollment By Investing.com - Investing.com Australia

Nov 03, 2025

Nov 03, 2025

Tscan Therapeutics stock plunges after pausing solid tumor trial enrollment - Investing.com

Nov 03, 2025

Nov 03, 2025

TScan Therapeutics Shifts Focus to Hematologic Malignancies - MSN

Nov 03, 2025

Nov 03, 2025

TScan Therapeutics Announces Positive Phase I Meeting with FDA, Strategic Workforce Reduction, and Focus on Hematologic Malignancies - Quiver Quantitative

Nov 03, 2025